Disclosure Of Intangible Assets [Text Block]

Zealand Pharma - Filing #1382857

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Disclosure of intangible assets [text block]
Disclosure of detailed information about intangible assets [text block]
Disclosure of detailed information about intangible assets [abstract]
Disclosure of detailed information about intangible assets [line items]
Reconciliation of changes in intangible assets other than goodwill [abstract]
Intangible assets other than goodwill
0 EUR
53,790,000 EUR
Research and development expense
614,044,000 EUR
581,511,000 EUR
595,847,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.